Kura Oncology Q3 2026 slides: KOMZIFTI revenue surges 53% sequentially

🌐 Investing.com (Cyprus) — 2026-11-11

Kura Oncology reported that KOMZIFTI revenue rose 53% sequentially, according to its Q3 2026 presentation slides. The headline provides no absolute revenue figures or further details about the company’s results.

Markets Health Kura Oncology KOMZIFTI Q3 2026 revenue growth biopharmaceuticals

Read original source →

Nigeria secures $3m investment in climate-smart agriculture at COP31
Punch Nigeria — 2026-11-11
Murphy Oil Draws Boycott Call Over Israeli Gas Licenses
Oilprice.com — 2026-11-11
Hims & Hers: Three Big Sacrifices
Seeking Alpha — 2026-11-11
Court Rules That Sexual Harassment Case Against SpaceX Can Proceed
New York Times Technology — 2026-11-11
CoreWeave: Things Aren't The Same (Rating Downgrade)
Seeking Alpha — 2026-11-11
Schneider National at Baird conference: margin repair in focus
Investing.com — 2026-11-11

Kura Oncology Q3 2026 slides: KOMZIFTI revenue surges 53% sequentially

AI Summary

Related Articles

Nigeria secures $3m investment in climate-smart agriculture at COP31

Murphy Oil Draws Boycott Call Over Israeli Gas Licenses

Hims & Hers: Three Big Sacrifices

Court Rules That Sexual Harassment Case Against SpaceX Can Proceed

CoreWeave: Things Aren't The Same (Rating Downgrade)

Schneider National at Baird conference: margin repair in focus